References
- Atroshi I, Englund M, Turkiewicz A, et al. Incidence of physician-diagnosed carpal tunnel syndrome in the general population. Arch Intern Med 2011;171:943–4.
- Werner RA, Albers JW, Franzblau A, Armstrong TJ. The relationship between body mass index and the diagnosis of carpal tunnel syndrome. Muscle Nerve 1994;17:632–6.
- Tseng CH, Liao CC, Kuo CM, et al. Medical and non-medical correlates of carpal tunnel syndrome in a Taiwan cohort of one million. Eur J Neurol 2012;19:91–7.
- Scholten RJPM, Mink van der Molen A, Uitdehaag BMJ, et al. Surgical treatment options for carpal tunnel syndrome. Cochrane Database Syst Rev 2007;(4):CD003905. doi: 10.1002/14651858.CD003905.pub3.
- Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006;23:469–80.
- Callaghan B, Feldman E. The metabolic syndrome and neuropathy: therapeutic challenges and opportunities. Ann Neurol 2013;74:397–403.
- Jeske O, Schuler M, Schumann P, et al. Planctomycetes do possess a peptidoglycan cell wall. Nat Commun 2015;6:7116.
- Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013;1:CD004816.
- Jeppesen U, Gaist D, Smith T, Sindrup SH. Statins and peripheral neuropathy. Eur J Clin Pharmacol 1999;54:835–8.
- Hunsaker FG, Cioffi DA, Amadio PC, et al. The American academy of orthopaedic surgeons outcomes instruments: normative values from the general population. J Bone Joint Surg Am 2002;84-A:208–15.
- Gummesson C, Atroshi I, Ekdahl C. The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: longitudinal construct validity and measuring self-rated health change after surgery. BMC Musculoskelet Disord 2003;4:11.
- Mintken PE, Glynn P, Cleland JA. Psychometric properties of the shortened disabilities of the arm, shoulder, and hand questionnaire (QuickDASH) and numeric pain rating scale in patients with shoulder pain. J Shoulder Elbow Surg 2009;18:920–6.
- Chammas M, Bousquet P, Renard E, et al. Dupuytren's disease, carpal tunnel syndrome, trigger finger, and diabetes mellitus. J Hand Surg Am 1995;20:109–14.
- Dahlin LB, Stenberg L, Luthman H, Thomsen NO. Nerve compression induces activating transcription factor 3 in neurons and Schwann cells in diabetic rats. Neuroreport 2008;19:987–90.
- Jenkins PJ, Duckworth AD, Watts AC, McEachan JE. The outcome of carpal tunnel decompression in patients with diabetes mellitus. J Bone Joint Surg Br 2012;94:811–14.
- Thomsen NO, Cederlund R, Rosen I, et al. Clinical outcomes of surgical release among diabetic patients with carpal tunnel syndrome: prospective follow-up with matched controls. J Hand Surg Am 2009;34:1177–87.
- Thomsen NO, Rosen I, Dahlin LB. Neurophysiologic recovery after carpal tunnel release in diabetic patients. Clin Neurophysiol 2010;121:1569–73.
- Ozkul Y, Sabuncu T, Kocabey Y, Nazligul Y. Outcomes of carpal tunnel release in diabetic and non-diabetic patients. Acta Neurol Scand 2002;106:168–72.
- Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care 2004;27:1458–86.
- Bland JD. The relationship of obesity, age, and carpal tunnel syndrome: more complex than was thought? Muscle Nerve 2005;32:527–32.
- Nakamichi K, Tachibana S. Hypercholesterolemia as a risk factor for idiopathic carpal tunnel syndrome. Muscle Nerve 2005;32: 364–7.
- Edwards L, Ring C, McIntyre D, et al. Cutaneous sensibility and peripheral nerve function in patients with unmedicated essential hypertension. Psychophysiology 2008;45:141–7.
- Bang CN, Okin PM. Statin treatment, new-onset diabetes, and other adverse effects: a systematic review. Curr Cardiol Rep 2014;16:461.
- Balci K, Utku U. Carpal tunnel syndrome and metabolic syndrome. Acta Neurol Scand 2007;116:113–17.
- Onder B, Yalcin E, Selcuk B, et al. Carpal tunnel syndrome and metabolic syndrome co-occurrence. Rheumatol Int 2013;33:583–6.